[
    [
        {
            "time": "2018-07-03",
            "original_text": "[买入评级]智飞生物(300122)：业绩维持高增长 HPV疫苗放量增加弹性",
            "features": {
                "keywords": [
                    "智飞生物",
                    "HPV疫苗",
                    "高增长",
                    "业绩"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[买入评级]智飞生物(300122)：业绩维持高增长 HPV疫苗放量增加弹性",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-07-03",
            "original_text": "[增持评级]医药生物行业周报：继续看好细分领域龙头 把握中报期的结构性机会",
            "features": {
                "keywords": [
                    "医药生物",
                    "细分领域",
                    "龙头",
                    "中报",
                    "结构性机会"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[增持评级]医药生物行业周报：继续看好细分领域龙头 把握中报期的结构性机会",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-07-03",
            "original_text": "智飞生物:业绩持续高增长, HPV疫苗贡献弹性",
            "features": {
                "keywords": [
                    "智飞生物",
                    "HPV疫苗",
                    "高增长",
                    "业绩"
                ],
                "sentiment_score": 0.88,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物:业绩持续高增长, HPV疫苗贡献弹性",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-07-03",
            "original_text": "中报表行情成大跌中一抹亮色 8股高速增长且低估",
            "features": {
                "keywords": [
                    "中报",
                    "高速增长",
                    "低估"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中报表行情成大跌中一抹亮色 8股高速增长且低估",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-07-03",
            "original_text": "[买入评级]智飞生物(300122)：业绩略超预期 自产+代理重磅品种正高速增长",
            "features": {
                "keywords": [
                    "智飞生物",
                    "自产",
                    "代理",
                    "重磅品种",
                    "高增长",
                    "业绩"
                ],
                "sentiment_score": 0.92,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[买入评级]智飞生物(300122)：业绩略超预期 自产+代理重磅品种正高速增长",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-07-03",
            "original_text": "2018年7月医药行业投资策略：目前 对医药可以更乐观点",
            "features": {
                "keywords": [
                    "医药",
                    "投资策略",
                    "乐观"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "2018年7月医药行业投资策略：目前 对医药可以更乐观点",
                "Correlation": 4,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 10,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-07-03",
            "original_text": "【平安】智飞生物*300122*重磅品种放量，增长预期兑现*推荐",
            "features": {
                "keywords": [
                    "智飞生物",
                    "重磅品种",
                    "放量",
                    "增长预期"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【平安】智飞生物*300122*重磅品种放量，增长预期兑现*推荐",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-07-03",
            "original_text": "[看好评级]医药生物行业周报：关注主营业务带来的中报业绩成长性",
            "features": {
                "keywords": [
                    "医药生物",
                    "主营业务",
                    "中报",
                    "业绩成长性"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[看好评级]医药生物行业周报：关注主营业务带来的中报业绩成长性",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-07-03",
            "original_text": "[推荐评级]医药行业周报：长期配置核心资产 短期关注高速个股的估值切换",
            "features": {
                "keywords": [
                    "医药",
                    "核心资产",
                    "估值切换",
                    "高速个股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[推荐评级]医药行业周报：长期配置核心资产 短期关注高速个股的估值切换",
                "Correlation": 4,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 2,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-07-03",
            "original_text": "[推荐评级]智飞生物(300122)：业绩预告高速增长 AC-HIB、HPV持续放量",
            "features": {
                "keywords": [
                    "智飞生物",
                    "AC-HIB",
                    "HPV",
                    "高增长",
                    "业绩预告"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[推荐评级]智飞生物(300122)：业绩预告高速增长 AC-HIB、HPV持续放量",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]